Quantcast
Last updated on April 18, 2014 at 1:21 EDT

Latest Multiple organ dysfunction syndrome Stories

2014-04-10 13:40:50

In the UK paracetamol toxicity is the most common cause of ALF and has a high mortality rate. It is estimated that 150 to 200 deaths and 15 to 20 LTs occur as a result of poisoning each year in England and Wales. LT is the definitive treatment for ALF patients who meet the criteria for transplantation but the current means of selection for LT (the King's College Criteria) are not ideal and do not assess changes in prognostic measures over time or quantify the mortality risk for individual...

2014-03-13 08:27:59

MONMOUTH JUNCTION, N.J., March 13, 2014 /PRNewswire/ -- CytoSorbents Corporation (OTCQB: CTSO), a critical care immunotherapy company using blood purification to treat life-threatening illnesses in the intensive care unit, announced that it will sponsor a research symposium entitled: "SIRS and SEPSIS - New Therapy with CytoSorb®" at the 34(th) International Symposium on Intensive Care and Emergency Medicine (ISICEM 2014) in Brussels, Belgium next week. The program is scheduled for...

2014-01-08 17:32:42

A special issue on sepsis has been released by the publisher Landes Bioscience (Austin, TX USA). The articles contained in this special issue of the journal Virulence have been authored by world-class investigators and provide new insights into both the pathogen-related factors and the host defense mechanisms that lead to septic shock and contribute to its resolution or fatal outcome. Sepsis, or septic shock, is an excessive inflammatory response in answer to a serious infection, most...

2013-09-24 10:58:46

Study shows need for improved detection of sepsis for all women in labor Rates of severe sepsis and deaths from sepsis among U.S. women hospitalized for delivery have risen sharply over the last decade, reports a study in the October issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS). "Maternal severe sepsis and sepsis-related deaths are increasing in the United States," concludes the report by Dr Melissa E. Bauer of University...

2013-09-12 08:30:53

BERLIN, September 12, 2013 /PRNewswire/ -- - Second World Sepsis Day on 13 September with high participation around the world With over 100 events in more than 40 countries on every continent, the response to this year's World Sepsis Day (WSD) is even greater than last year's. Global Sepsis Alliance and WSD 2013 supporters in every country have one message: by implementing the guidelines for the prevention and management of sepsis, the rapid increase in the number of...

2013-05-29 08:32:06

MONMOUTH JUNCTION, N.J., May 29, 2013 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to treat life-threatening illnesses in the intensive care unit, was recently featured in the article "Blood Purification Device for ICU Patients Seeks to Treat Root Cause of Sepsis" on May 24, 2013 in MedCity News. Highlights from the MedCity News Article: The cost of treating sepsis was $14.6 billion in 2008, according to the Centers for...

2013-04-01 12:57:37

Could improve treatments for pneumonia and other inflammatory conditions Scientists at the University of Pittsburgh School of Medicine have discovered a new biological pathway of innate immunity that ramps up inflammation and then identified agents that can block it, leading to increased survival and improved lung function in animal models of pneumonia. They reported their findings today in Nature Immunology. Pneumonia and other infections sometimes provoke an inflammatory response from...

2012-09-07 02:24:21

MONMOUTH JUNCTION, N.J., Sept. 7, 2012 /PRNewswire/ -- CytoSorbents Corporation (OTCBB: CTSO), a critical care focused company using blood purification to modulate the immune system, reduce severe inflammation, and fight organ failure caused by life-threatening illnesses such as sepsis, announced that it has become a member and sponsor of the Germany Sepsis Society and a sponsor of the Sepsis Heroes Evening, hosted by the Sepsis Alliance, in honor of the first World Sepsis Day on...

2012-03-12 06:32:00

SAN DIEGO, March 12, 2012 /PRNewswire/ -- InflammaGen(TM) Therapeutics, a development-stage, critical care company initially focused on the diagnosis, treatment and prevention of multi-organ failure (MOF), announced today that the Company has initiated a 200-patient Phase 2 pilot study to examine the efficacy and safety of InflammaGen Shok-Pak as a potential treatment for critically ill patients in the Intensive Care Unit (ICU). Conditions expected to qualify for the study include new-onset...

2012-02-13 06:19:00

TEL-AVIV, Israel and VANCOUVER, Canada, February 13, 2012 /PRNewswire/ -- Cheetah Medical [http://www.cheetah-medical.com ], a leader in non-invasive hemodynamic monitoring announced today the launch of a multicenter clinical study evaluating a novel, aggressive approach for management of sepsis. The study's goal is to reduce progression and morbidity from sepsis. The study, called Cardiac Output Monitoring Managing Intravenous Therapy (COMMIT) to Treat Emergency Department...